James P. Conn is Director at Gabelli Healthcare & WellnessRx Trust (GRX). They have made 40 open-market trades across 14 companies since 2007, most recently 2026-01-27.
CIK 0001216778
14 open-market purchases totalling $721K since 2007, against 26 sales. Across 14 scored buys the stock is up 1.5% at ninety days, and 0.9 points behind the S&P over the same stretch.
14 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 21% | 43% | 57% |
| Avg Move | -3.6% | +0.1% | +1.5% |
| Alpha | -0.1% | -0.7% | -0.9% |
| Scored | 14 | 14 | 14 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GDV | BUY | 2026-01-27 | 2026-01-28 | $28.73 | $29K | +1.6% | +0.5% | +1.6% |
| GUT.RT | SELL | 2024-10-16 | 2024-10-23 | $0.02 | $6 | N/A | N/A | N/A |
| GDL | BUY | 2020-04-20 | 2020-04-22 | $7.91 | $8K | +1.6% | +5.8% | +6.9% |
| GRX | SELL | 2019-11-15 | 2019-11-19 | $10.89 | $498K | +1.1% | +2.7% | +7.9% |
| GRX | SELL | 2019-11-11 | 2019-11-13 | $10.71 | $448K | +4.1% | +2.9% | +8.9% |
| GRX | SELL | 2019-11-07 | 2019-11-08 | $10.63 | $308K | +3.2% | +5.9% | +10.7% |
| GRX | SELL | 2019-09-26 | 2019-09-30 | $10.45 | $94K | -2.1% | +0.4% | +9.7% |
| GRX | SELL | 2019-09-20 | 2019-09-24 | $10.56 | $89K | -2.6% | -1.4% | +8.9% |
| GRX | SELL | 2019-09-19 | 2019-09-23 | $10.57 | $21K | -3.1% | -1.0% | +8.8% |
| GRX | SELL | 2019-09-12 | 2019-09-13 | $10.68 | $107K | +0.0% | -3.7% | +6.2% |
| GLU | SELL | 2019-09-09 | 2019-09-10 | $17.93 | $134K | +2.0% | +1.8% | +4.2% |
| GDL | SELL | 2019-09-06 | 2019-09-10 | $9.20 | $28K | -0.2% | -2.0% | -1.5% |
| GLU | SELL | 2019-09-06 | 2019-09-09 | $18.02 | $450K | +2.4% | +2.4% | +4.7% |
| GGZ | SELL | 2019-09-06 | 2019-09-09 | $10.89 | $304K | +1.5% | -2.7% | +5.5% |
| GGN | SELL | 2019-09-06 | 2019-09-09 | $4.46 | $18K | -1.4% | -2.7% | -3.2% |
| GNT | SELL | 2019-09-06 | 2019-09-09 | $5.60 | $11K | +3.9% | +5.9% | +10.2% |
| GGT | SELL | 2019-09-06 | 2019-09-09 | $8.52 | $445K | -1.3% | -5.2% | -4.2% |
| GGT | SELL | 2019-08-30 | 2019-09-04 | $8.22 | $49K | +0.4% | -4.0% | -3.1% |
| GRX | SELL | 2019-08-29 | 2019-09-03 | $10.41 | $129K | +2.8% | -1.1% | +7.9% |
| GDL | SELL | 2019-08-29 | 2019-09-03 | $9.26 | $204K | +1.1% | -0.3% | -0.2% |
| GLU | SELL | 2019-08-28 | 2019-08-30 | $17.95 | $22K | +1.3% | +3.0% | +3.2% |
| GAB | SELL | 2019-08-27 | 2019-08-29 | $5.98 | $642K | +1.2% | -1.5% | +1.3% |
| GAB | SELL | 2019-08-23 | 2019-08-27 | $5.97 | $317K | +3.4% | +0.8% | +3.2% |
| GLU | SELL | 2019-08-23 | 2019-08-27 | $18.00 | $7K | +0.1% | +3.2% | +4.1% |
| GDV | SELL | 2018-11-01 | 2018-11-05 | $20.80 | $104K | -0.1% | -2.8% | -2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| GRX |
| 1,000 |
| $10K |
| GUT | 1,507 | $9K |
| GNT | 1,000 | $9K |
| GAB | 1,100 | $6K |
| GGN | 1,000 | $5K |
| GUT.RT | 1,000 | — |
| GDL.A | 1,500 | — |
| GDL.B | 2,250 | — |
| GGT.B | 818 | — |
| GLU.A | 1,667 | — |
| GLU.B | 1,000 | — |
| GRX.A | 1,000 | — |
| Total | $170K |
Shares reported on the most recent Form 4, priced at the 2026-01-28 close. 7 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.